Drugs Health Research

Cincinnati team’s lab-made lung tissue produces its own blood vessels

HQ Team July 1, 2025: Medical experts at Cincinnati Children’s have made an organoid, or ‘organs in a dish,’ of human lung tissue.

Read More
Drugs Health Pharma

WHO says more information needed to track SARS-CoV-2 origins

HQ Team June 30, 2025: The two hypothetical origins of the Covid-19 pandemic, namely the animal-to-human transmission and a laboratory leak, remain on.

Read More
Drugs Health Pharma

Novavax’s Covid-19-influenza vaccine trial yields ‘strong’ immune response

HQ Team June 12, 2025: Novavax Inc.’s investigational vaccine that protects against both Covid-19 and seasonal flu in a single shot has generated.

Read More
Climate Health Research

Bat family virus, similar to MERS-CoV, has potential to cause a pandemic

 HQ Team June 9, 2025: A virus belonging to the bat family, and closely related to the deadly Middle East respiratory syndrome coronavirus.

Read More
Drugs Health Pharma

India’s active Covid-19 cases nears 4,000-mark, 32 deaths since January

HQ Team June 3, 2025: The number of active Covid-19 cases in India approached the 4,000-mark, with 161 people infected with the disease.

Read More
Drugs Health Pharma

US terminates Moderna contract for investigational bird flu vaccine

HQ Team May 29, 2025: The US Department of Health and Human Services has terminated a contract awarded to Moderna Inc. for the.

Read More
Drugs Health Pharma

Global virologists see potential for an H5N1 pandemic, urge rapid steps

HQ Team May 5, 2025: The Global Virus Network warned of an avian influenza currently circulating in the US, spreading to humans and.

Read More
Climate Drugs Health

A new pandemic like Covid-19 is ‘epidemiological certainty’: WHO

HQ Team April 13, 2025: A new pandemic like Covid-19 is “not a theoretical risk, it is an epidemiological certainty,” said the World.

Read More
Health Research

COVID-19 increases risk of other infections, study finds

HQ Team April 5, 2025: A recent study reveals that COVID-19 patients face increased risks of other infections for at least a year.

Read More
Drugs Medical Pharma

Organon & Co. buys biosimilar from Biogen for an undisclosed sum

HQ Team April 2, 2025: Organon has acquired the commercial rights for a biosimilar for intravenous infusion in treating arthritis and Covid-19 from.

Read More